Infections remain one of the major causes of death worldwide and we face increasing antibiotic resistance, emerging and re-emerging infectious diseases and their global spread due to the globalization and global mobility. Also, development and application of therapies with maximum efficacy and minimum toxicity remain a fundamental challenge. Thus, new and innovative approaches to optimize clinical care for patients suffering from or being threatened by infectious diseases will be of increasing importance. Tailored therapeutic strategies based on detailed molecular stratification of disease sub-entities have been pioneered in oncology, where characterization of key mutations and molecular pathways already guide diagnostics and therapeutic intervention. Such concepts of individualized medicine and custom-made therapies for each patient also holds untapped potential with a view to the diagnostic workup and treatment of infections. Realizing this potential will require evolving, combining and applying leading know-how and cutting-edge technologies to establish the highest quality of individualized medicine possible.
This symposium aims at fostering international and interdisciplinary collaboration by bringing together outstanding experts from different fields to address major scientific questions, tackle ethical, social and economical considerations and discuss the requirements for regulation processes in individualized medicine. The exchange of ideas and resulting discussions will help to guide the path forward for individualized medicine as a whole and individualized infection medicine in particular.
This Herrenhausen Symposium is jointly organized by the Volkswagen Foundation the Hannover Medical School and the Helmholtz Centre for Infection Research (HZI), Braunschweig.
Herrenhausen Symposium "Individualized Infection Medicine - The future is now"
June 21 - 23, 2018
Herrenhausen Palace, Hanover, Germany
The preliminary program can be downloaded in the column on the right. Please note that it is still under construction and changes may occur.
Confirmed Speakers include
(all academic titles have been omitted)
Edward Abrahams (Personalized Medicine Coalition, USA)
Marylyn Addo (University Medical Center Hamburg-Eppendorf, Germany)
Ralf Bartenschlager (Heidelberg University Hospital, Germany)
Alena Buyx (Christian-Albrechts-University Kiel, Germany)
Markus Cornberg (Hannover Medical School, Germany)
Tobias Feuchtinger (Dr. von Hauner Children's Hospital, LUM Munich, Germany)
Susanne Häussler (Helmholtz Centre for Infection Research, Germany)
Thomas Illig (Hannover Medical School, Germany)
Beate Kampmann (Imperial College London, UK)
Paul Kellam (Imperial College London, UK)
Steven Kern (Bill and Melinda Gates Foundation, USA)
Christoph Klein (Dr. von Hauner Children's Hospital, LUM Munich, Germany)
Heyo Kroemer (University Medical Center Göttingen, Germany)
Martin Krönke (University Hospital Cologne, Germany)
Thomas Lengauer, (Max-Planck Institute for Informatics, Germany)
Nisar Malek (University Hospital Tübingen, Germany)
Alice McHardy (Helmholtz Centre for Infection Research, Germany)
Michel Nussenzweig (Rockefeller University, USA)
Peter Openshaw (Imperial College London, UK)
Eric Pamer (Memorial Sloan Kettering Cancer Center, USA)
Hagen Pfundner (Roche Pharma AG, Germany)
Keith Stewart (Mayo Clinic, Centre for Individualised Medicine, USA)
Fabian Theis (Helmholtz Centre Munich, Germany)
Christoph von Kalle (NCT Heidelberg, Germany)
Otmar Wiestler (Helmholtz Association, Germany)
Christopher Woods (Duke Center for Applied Genomics and Precision Medicine, USA)
Osmar Zaïane (University of Alberta, Canada)
There are no fees for attendance but registration is essential. If you would like to attend the conference, please register by clicking on the registration link.
The conference language is English.
Abstract Submission and Travel Grants
Interested researchers are invited to submit an abstract. All submitted abstracts will be evaluated by the steering committee and selected abstracts will be presented in a poster session during the Symposium. Please submit your abstract until March 30, 2018 via www.helmholtz-hzi.de/hs_travel_grants. You will be informed whether your abstract has been selected by April 2018.
Applications for travel grants offered by the Volkswagen Foundation are no longer accepted as the deadline expired. Selected applicants will be informed in February 2018 and will get the chance to present their research in a poster and/or lightning talk session. The posters will be displayed during the entire symposium.
Credit Points for German Physicians
Approved as "Fortbildungsveranstaltung gemäß der Fortbildungsordnung der Ärztekammer Niedersachsen" with 18 credit points, event number: 2760302018002260002, www.aekn.de and accredited by the "Akademie für Infektionsmedizin e.V." with 20 iCME.
Venue and Public Transport
The conference is held at Herrenhausen Palace, a modern conference center in Hanover, Germany. You can reach the venue by tram: Take line 4 or 5 and get off at "Herrenhäuser Gärten".
Accommodation for Participants
Please note that you are responsible for booking your accommodation. As Hanover is a city that hosts many fairs, we recommend booking a hotel as soon as you register.
Please cancel your registration if you cannot attend the conference. We have a waiting list for the meeting and can offer your place to another person if you cannot attend. Simply use the registration tool to cancel or send us an email.